
Bioscan Research leverages deep tech in optics, electronics, mechanics, and software to develop, test, manufacture, and commercialize affordable medical devices for the non-invasive early detection of life-threatening diseases. Their primary product, CEREBO®, is an onsite, portable, and non-invasive neurological scan device designed for rapid triaging of traumatic intracranial hemorrhage. It utilizes Near-Infrared Spectroscopy (NIRS) and machine learning algorithms to provide quick and accurate diagnoses at the point of care, aiming to improve patient outcomes by enabling faster treatment. The company targets trauma centers, ambulances, emergency wards, and other first-response sites, as well as injury-prone locations like sports facilities and schools. Bioscan Research emphasizes the device's ease of use, minimal training requirement, and patented zero calibration system, bridging the gap left by traditional CT scanners which are less portable and require more infrastructure.

Bioscan Research leverages deep tech in optics, electronics, mechanics, and software to develop, test, manufacture, and commercialize affordable medical devices for the non-invasive early detection of life-threatening diseases. Their primary product, CEREBO®, is an onsite, portable, and non-invasive neurological scan device designed for rapid triaging of traumatic intracranial hemorrhage. It utilizes Near-Infrared Spectroscopy (NIRS) and machine learning algorithms to provide quick and accurate diagnoses at the point of care, aiming to improve patient outcomes by enabling faster treatment. The company targets trauma centers, ambulances, emergency wards, and other first-response sites, as well as injury-prone locations like sports facilities and schools. Bioscan Research emphasizes the device's ease of use, minimal training requirement, and patented zero calibration system, bridging the gap left by traditional CT scanners which are less portable and require more infrastructure.